Stroke - Nursing Case Study

Pathophysiology

• Primary mechanism: Ischemic stroke occurs when a blood clot obstructs a cerebral artery, reducing blood flow and oxygen supply to brain tissue, leading to cell death and neurological deficits.

• Secondary mechanism: Hemorrhagic stroke results from a ruptured blood vessel, causing bleeding into or around the brain, increasing intracranial pressure and disrupting normal brain function.

• Key complication: Both types of strokes can lead to cerebral edema, which exacerbates brain injury by compressing delicate structures and further impairing blood flow.

Patient Profile

Demographics:

67-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden weakness on the right side of the body

• Key symptoms: Slurred speech, difficulty walking, facial droop on the right side, headache

• Vital signs: Blood pressure 185/95 mmHg, heart rate 95 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the initial assessment continues, the healthcare team focuses on the neurological evaluation of the patient. The National Institutes of Health Stroke Scale (NIHSS) is administered, revealing moderate deficits with a score of 14. This score suggests significant impairment, particularly in areas related to communication and motor function. The patient's slurred speech persists, and she struggles to articulate words, indicating aphasia. Additionally, the right-sided weakness is more pronounced, with diminished strength in both the right arm and leg, contributing to an unsteady gait and increased fall risk. A CT scan of the brain is promptly ordered to differentiate between ischemic and hemorrhagic stroke, guiding further management.

Shortly after the initial assessment, new diagnostic results become available. The CT scan confirms an ischemic stroke, showing an area of hypodensity in the left middle cerebral artery territory, consistent with an acute infarct. Laboratory tests reveal elevated blood glucose levels at 260 mg/dL, which correlates with her history of Type 2 Diabetes and could potentially exacerbate the ischemic injury. Blood urea nitrogen and creatinine levels are within normal range, ruling out acute kidney injury as a complication of her condition. However, lipid panel results show elevated LDL cholesterol at 160 mg/dL, reaffirming her risk for vascular disease.

As the team processes these findings, they decide to initiate tissue plasminogen activator (tPA) therapy, given the ischemic nature of the stroke and the absence of contraindications. The patient's blood pressure is closely monitored, as it remains elevated at 180/92 mmHg, posing a risk for further vascular complications. The healthcare team discusses the need for tight glycemic control and considers adjusting her diabetic management to prevent further hyperglycemic episodes. With the tPA administered and supportive care ongoing, the patient's condition remains critical, requiring vigilant monitoring for potential complications such as cerebral edema or hemorrhagic transformation, which could alter her clinical trajectory.

Section 2

As the healthcare team continues to monitor the patient closely following the administration of tPA, a new complication arises. Approximately 12 hours after the intervention, the patient begins to exhibit signs of increased intracranial pressure (ICP). She becomes increasingly lethargic, with a decreased level of consciousness noted during neurological assessments. Her pupils are unequal, with the right pupil showing slower reactivity to light compared to the left. The team suspects the development of cerebral edema, a known complication following ischemic stroke and thrombolytic therapy.

Vital signs indicate further deterioration: the patient's blood pressure rises to 190/100 mmHg, and her heart rate decreases to 58 beats per minute. These findings suggest a possible Cushing's triad, which is indicative of elevated ICP. The team promptly orders a repeat CT scan of the brain, which reveals a slight midline shift and increased swelling in the left hemisphere, although no evidence of hemorrhagic transformation is present at this time. In response, the healthcare providers initiate measures to manage the increased ICP, including elevating the head of the bed to 30 degrees and administering mannitol to reduce cerebral edema.

The patient's glucose levels remain elevated, despite adjustments to her diabetic regimen, with a current reading of 245 mg/dL. The team emphasizes the need for tighter glycemic control, recognizing the role of hyperglycemia in worsening cerebral outcomes. As they plan the next steps, the healthcare providers are keenly aware of the delicate balance required to manage the patient’s conditions, focusing on stabilizing her neurological status while preventing further complications. Regular reassessment and interdisciplinary collaboration become crucial as they work towards optimizing the patient's recovery trajectory.

Section 3

As the healthcare team continues to manage the patient's increased intracranial pressure, they closely monitor her response to the interventions, particularly the administration of mannitol. Over the next few hours, there is a modest improvement in her neurological status. The patient shows slight responsiveness to verbal stimuli, and her pupils become more equal in size, although the right pupil still demonstrates sluggish reactivity. Vital signs indicate a subtle shift: her blood pressure stabilizes to 170/95 mmHg, while her heart rate slightly increases to 62 beats per minute. These changes suggest a partial response to the therapeutic measures, yet the team remains vigilant for any signs of deterioration.

Despite these improvements, the patient's glucose levels persistently hover around 240 mg/dL. Recognizing the critical impact of hyperglycemia on cerebral edema and stroke outcomes, the medical team intensifies their efforts in glycemic control. An endocrinology consult is initiated to fine-tune her insulin regimen, aiming for a target glucose level of 140-180 mg/dL. Meanwhile, the nursing staff diligently monitors her blood sugar levels every two hours, adjusting insulin doses as necessary. This integrated approach underscores the importance of managing metabolic disturbances alongside neurological complications.

As the patient remains in the intensive care unit, the multidisciplinary team continues to reassess her condition regularly, coordinating care to prevent secondary complications. They prepare for potential interventions, such as hypertonic saline administration or surgical decompression, should the patient's ICP fail to decrease further. This ongoing vigilance and adaptability in care planning emphasize the dynamic nature of stroke management and the critical role of early intervention in optimizing outcomes for patients with complex clinical presentations.

Section 4

As the evening progresses, the patient's clinical status begins to show signs of potential complications, demanding heightened vigilance from the healthcare team. Despite initial improvements, the patient's neurological examination reveals new concerns: her level of consciousness regresses slightly, now only responsive to painful stimuli. The right pupil, which had previously shown sluggish reactivity, becomes fixed and dilated. These findings raise alarms for possible worsening of her intracranial pressure. Concurrent with these changes, her blood pressure climbs to 185/105 mmHg, and her heart rate drops to 58 beats per minute, indicating potential Cushing's triad—a critical sign of increased intracranial pressure that requires immediate attention.

Laboratory results further complicate the clinical picture. The patient develops hyponatremia, with serum sodium levels dropping to 130 mmol/L. This electrolyte imbalance could exacerbate cerebral edema, prompting the team to consider the administration of hypertonic saline. The combination of these symptoms suggests that the interventions, while initially effective, may not be sufficient to manage the evolving intracranial dynamics. The team debates the necessity of a neurosurgical consult to evaluate the potential need for decompressive craniectomy, balancing the risks and benefits of surgical intervention.

In response to these developments, the multidisciplinary team intensifies their monitoring and adjusts the treatment plan. The patient is placed on continuous EEG monitoring to assess for seizure activity, given the altered mental status and electrolyte imbalance. The nursing staff increases the frequency of neurological assessments to every 15 minutes, ensuring any further deterioration is swiftly addressed. The endocrinology team reassesses her insulin regimen, fine-tuning doses to achieve better glycemic control, as hyperglycemia continues to pose a risk for worsened outcomes. This evolving clinical scenario underscores the complexity of stroke management, where timely recognition and intervention remain pivotal in preventing further complications and optimizing patient recovery.

Section 5

The team decides to address the patient's worsening hyponatremia and potential cerebral edema by initiating a carefully controlled infusion of hypertonic saline. Within the first two hours of administration, the serum sodium level shows a slight improvement, rising to 132 mmol/L. However, as the night progresses, the patient's neurological status continues to decline. Her Glasgow Coma Scale (GCS) score drops further to 7, necessitating intubation to protect her airway. This development prompts the team to prioritize maintaining adequate cerebral perfusion and oxygenation while preventing secondary brain injury.

Concurrent with these interventions, new diagnostic imaging results reveal a significant midline shift, suggesting increased intracranial pressure and possible herniation risk. The fixed and dilated right pupil, combined with the imaging findings, indicates that the intracranial dynamics are worsening despite medical management. The neurosurgical team is urgently consulted to evaluate the feasibility and timing of a decompressive craniectomy, weighing the potential benefits of alleviating pressure against the risks of surgical complications.

Despite these efforts, the patient's blood pressure remains elevated at 190/110 mmHg, and bradycardia persists with a heart rate of 55 beats per minute, reinforcing the presence of Cushing's triad. The multidisciplinary team convenes to reassess the treatment strategy, emphasizing the importance of swift surgical intervention alongside aggressive medical management to stabilize the patient's condition. The complexity of the situation requires a coordinated approach, with each team member contributing their expertise to optimize outcomes and prevent further neurological decline. As the next steps unfold, the patient's journey highlights the critical balance between aggressive intervention and careful monitoring in the management of severe stroke complications.